Status:
COMPLETED
Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma
Lead Sponsor:
University of Southern California
Conditions:
Uterine Cervical Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is first to establish what is the ideal dose of gemcitabine, a chemotherapy agent, when given in combination with radiation. In addition, the investigators want to determine ...
Eligibility Criteria
Inclusion
- Patients with histologically confirmed bulky stage Ib or stage IIa cervical cancer. Bulky stage Ib disease is defined as tumor mass greater than 4 cms in diameter.
- Cervical lesion which is measurable by physical examination.
- No prior therapy for invasive cervical cancer.
- GOG performance status 0-2
- Signed informed consent
- Patients must have adequate:
- Bone marrow function: absolute granulocyte count \> or = to 1500, platelet count \> 100,000.
- Renal function: creatinine \< or = to 1.8 mg/dl
- Hepatic function: bilirubin \< or = to 1.5 x normal, SGOT and alkaline phosphatase \< or = to 3 x normal
Exclusion
- Patients with a history of prior malignancy, except adequately treated basal cell or squamous cell carcinoma of the skin, or other cancer for which the patient has been disease free for at least five years.
- Pregnant or lactating women. Women of reproductive age may not participate unless they have agreed to use an effective method of birth control.
- Patients with uncontrolled infection.
- Patients who are HIV positive
- Patients with psychiatric or social conditions that would interfere with consent or follow-up.
- Patients with any other severe concurrent disease, which, in the judgment of the investigator, would make the patient inappropriate for entry into this study.
Key Trial Info
Start Date :
June 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00184093
Start Date
June 1 1999
End Date
May 1 2009
Last Update
August 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
USC/Norris Comprehensive Cancer Center
Los Angeles, California, United States, 90033